{"transactions":[{"id":736156,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T20:17:19.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":11389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 15, 2027 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":11389,"derivative":{"exercise_price":49.56,"expiration_date":"2036-06-15","underlying":"Common Stock","underlying_shares":11389},"source":{"system":"sec-edgar","filing":"0001829111-26-000009","document":"wk-form4_1781641036.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000182911126000009/wk-form4_1781641036.xml","form_type":"4"}},{"id":736155,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T20:17:19.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":2265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 15, 2027 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date. Pursuant to the Issuer's Nonqualified RSU Deferral Program for Non-Employee Directors, the Reporting Person has deferred delivery of all of such vested RSUs to the earlier of (i) a separation from service, or (ii) a qualifying change in control ."}],"balance_after":12481,"source":{"system":"sec-edgar","filing":"0001829111-26-000009","document":"wk-form4_1781641036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000182911126000009/wk-form4_1781641036.xml","form_type":"4"}},{"id":826426,"issuer":{"id":4567,"kind":"organization","name":"COMPASS Pathways plc"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2026-03-28T01:52:33.000Z","date":"2026-03-26","kind":"grant","planned":false,"acquired":true,"shares":157635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The share option shall vest in forty-eight equal monthly installments beginning on April 26, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":157635,"derivative":{"exercise_price":5.64,"exercise_date":"2026-04-26","expiration_date":"2036-03-25","underlying":"Ordinary Shares","underlying_shares":157635},"source":{"system":"sec-edgar","filing":"0001829111-26-000007","document":"wk-form4_1774662750.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816590/000182911126000007/wk-form4_1774662750.xml","form_type":"4"}},{"id":826425,"issuer":{"id":4567,"kind":"organization","name":"COMPASS Pathways plc"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-28T01:52:33.000Z","date":"2026-03-26","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an award of Restricted Share Units (\"RSUs\") granted under the Issuer's 2020 Share Option and Incentive Plan. Each RSU represents a contingent right to receive one Ordinary Share. The RSUs vest in four equal annual installments, with the first installment vesting on March 26, 2027."}],"balance_after":152002,"source":{"system":"sec-edgar","filing":"0001829111-26-000007","document":"wk-form4_1774662750.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816590/000182911126000007/wk-form4_1774662750.xml","form_type":"4"}},{"id":844030,"issuer":{"id":4567,"kind":"organization","name":"COMPASS Pathways plc"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-13T21:03:11.000Z","date":"2026-03-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":1781,"price":6.89,"value":12271.09,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer upon vesting of restricted share units to satisfy tax withholding obligations."}],"balance_after":77002,"source":{"system":"sec-edgar","filing":"0001829111-26-000004","document":"wk-form4_1773435787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816590/000182911126000004/wk-form4_1773435787.xml","form_type":"4"}},{"id":867989,"issuer":{"id":4567,"kind":"organization","name":"COMPASS Pathways plc"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-04T00:58:25.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":4467,"price":7.02,"value":31358.34,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer upon vesting of restricted share units to satisfy tax withholding obligations."}],"balance_after":78783,"source":{"system":"sec-edgar","filing":"0001829111-26-000002","document":"wk-form4_1772585901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816590/000182911126000002/wk-form4_1772585901.xml","form_type":"4"}},{"id":1109758,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-16T22:10:12.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":15372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 12, 2026 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":15372,"derivative":{"exercise_price":34.46,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":15372},"source":{"system":"sec-edgar","filing":"0001829111-25-000002","document":"wk-form4_1750111806.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000182911125000002/wk-form4_1750111806.xml","form_type":"4"}},{"id":1109757,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-16T22:10:12.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":3041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 12, 2026 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":10216,"source":{"system":"sec-edgar","filing":"0001829111-25-000002","document":"wk-form4_1750111806.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000182911125000002/wk-form4_1750111806.xml","form_type":"4"}},{"id":1207877,"issuer":{"id":4567,"kind":"organization","name":"COMPASS Pathways plc"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2025-03-13T12:15:29.000Z","date":"2025-03-11","kind":"grant","planned":false,"acquired":true,"shares":76000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The share option shall vest in forty-eight equal monthly installments beginning on April 11, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":76000,"derivative":{"exercise_price":3.6,"exercise_date":"2025-04-11","expiration_date":"2035-03-10","underlying":"Ordinary Shares","underlying_shares":76000},"source":{"system":"sec-edgar","filing":"0001816590-25-000025","document":"wk-form4_1741868121.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816590/000181659025000025/wk-form4_1741868121.xml","form_type":"4"}},{"id":1207876,"issuer":{"id":4567,"kind":"organization","name":"COMPASS Pathways plc"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-13T12:15:29.000Z","date":"2025-03-11","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an award of Restricted Share Units (\"RSUs\") granted under the Issuer's 2020 Share Option and Incentive Plan. Each RSU represents a contingent right to receive one Ordinary Share. The RSUs vest in four equal annual installments, with the first installment vesting on March 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents an award of Restricted Share Units (\"RSUs\") granted under the Issuer's 2020 Share Option and Incentive Plan. Each RSU represents a contingent right to receive one Ordinary Share. The RSUs vest in four equal annual installments, with the first installment vesting on March 11, 2026."}],"balance_after":83250,"source":{"system":"sec-edgar","filing":"0001816590-25-000025","document":"wk-form4_1741868121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816590/000181659025000025/wk-form4_1741868121.xml","form_type":"4"}},{"id":1229218,"issuer":{"id":4567,"kind":"organization","name":"COMPASS Pathways plc"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-04T22:54:45.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":4468,"price":3.67,"value":16397.56,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer upon vesting of restricted share units to satisfy tax withholding obligations."}],"balance_after":58250,"source":{"system":"sec-edgar","filing":"0001816590-25-000020","document":"wk-form4_1741128876.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816590/000181659025000020/wk-form4_1741128876.xml","form_type":"4"}},{"id":1300099,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-17T21:05:42.000Z","date":"2025-01-15","kind":"exercise","planned":true,"acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Option is fully vested and exercisable."}],"balance_after":6250,"derivative":{"exercise_price":22.7,"expiration_date":"2032-05-31","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001649094-25-000006","document":"wk-form4_1737147935.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000006/wk-form4_1737147935.xml","form_type":"4"}},{"id":1300098,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-17T21:05:42.000Z","date":"2025-01-15","kind":"sale","planned":true,"acquired":false,"shares":529,"price":88.536,"value":46835.544,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 18, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $87.915 to $88.91. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":7175,"source":{"system":"sec-edgar","filing":"0001649094-25-000006","document":"wk-form4_1737147935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000006/wk-form4_1737147935.xml","form_type":"4"}},{"id":1300097,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-17T21:05:42.000Z","date":"2025-01-15","kind":"sale","planned":true,"acquired":false,"shares":1013,"price":87.377,"value":88512.901,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 18, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $86.89 to $87.75. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":7704,"source":{"system":"sec-edgar","filing":"0001649094-25-000006","document":"wk-form4_1737147935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000006/wk-form4_1737147935.xml","form_type":"4"}},{"id":1300096,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-17T21:05:42.000Z","date":"2025-01-15","kind":"sale","planned":true,"acquired":false,"shares":966,"price":86.257,"value":83324.262,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 18, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $85.89 to $86.59. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":8717,"source":{"system":"sec-edgar","filing":"0001649094-25-000006","document":"wk-form4_1737147935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000006/wk-form4_1737147935.xml","form_type":"4"}},{"id":1300095,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-17T21:05:42.000Z","date":"2025-01-15","kind":"sale","planned":true,"acquired":false,"shares":1043,"price":85.293,"value":88960.599,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 18, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $84.83 to $85.73. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":9683,"source":{"system":"sec-edgar","filing":"0001649094-25-000006","document":"wk-form4_1737147935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000006/wk-form4_1737147935.xml","form_type":"4"}},{"id":1300094,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-17T21:05:42.000Z","date":"2025-01-15","kind":"sale","planned":true,"acquired":false,"shares":1202,"price":83.931,"value":100885.062,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 18, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $83.51 to $84.37. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":10726,"source":{"system":"sec-edgar","filing":"0001649094-25-000006","document":"wk-form4_1737147935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000006/wk-form4_1737147935.xml","form_type":"4"}},{"id":1300093,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-17T21:05:42.000Z","date":"2025-01-15","kind":"sale","planned":true,"acquired":false,"shares":1136,"price":82.894,"value":94167.584,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 18, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $82.455 to $83.42. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":11928,"source":{"system":"sec-edgar","filing":"0001649094-25-000006","document":"wk-form4_1737147935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000006/wk-form4_1737147935.xml","form_type":"4"}},{"id":1300092,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-17T21:05:42.000Z","date":"2025-01-15","kind":"sale","planned":true,"acquired":false,"shares":215,"price":81.534,"value":17529.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 18, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $81.36 to $81.735. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":13064,"source":{"system":"sec-edgar","filing":"0001649094-25-000006","document":"wk-form4_1737147935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000006/wk-form4_1737147935.xml","form_type":"4"}},{"id":1300091,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-17T21:05:42.000Z","date":"2025-01-15","kind":"sale","planned":true,"acquired":false,"shares":146,"price":80.46,"value":11747.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 18, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $80.32 to $80.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":13279,"source":{"system":"sec-edgar","filing":"0001649094-25-000006","document":"wk-form4_1737147935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000006/wk-form4_1737147935.xml","form_type":"4"}},{"id":1300090,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-17T21:05:42.000Z","date":"2025-01-15","kind":"exercise","planned":true,"acquired":true,"shares":6250,"price":22.7,"value":141875.0,"ownership":{"direct":true},"balance_after":13425,"source":{"system":"sec-edgar","filing":"0001649094-25-000006","document":"wk-form4_1737147935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909425000006/wk-form4_1737147935.xml","form_type":"4"}},{"id":1403596,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-18T20:24:45.000Z","date":"2024-09-17","kind":"exercise","planned":true,"acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Option is fully vested and exercisable."}],"balance_after":12500,"derivative":{"exercise_price":22.7,"expiration_date":"2032-05-31","underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001649094-24-000069","document":"wk-form4_1726691078.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000069/wk-form4_1726691078.xml","form_type":"4"}},{"id":1403595,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-18T20:24:45.000Z","date":"2024-09-17","kind":"sale","planned":true,"acquired":false,"shares":256,"price":117.51,"value":30082.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 18, 2024."}],"balance_after":7175,"source":{"system":"sec-edgar","filing":"0001649094-24-000069","document":"wk-form4_1726691078.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000069/wk-form4_1726691078.xml","form_type":"4"}},{"id":1403594,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-18T20:24:45.000Z","date":"2024-09-17","kind":"sale","planned":true,"acquired":false,"shares":4308,"price":116.6172,"value":502386.8976,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 18, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $116.25 to $117.04. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":7431,"source":{"system":"sec-edgar","filing":"0001649094-24-000069","document":"wk-form4_1726691078.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000069/wk-form4_1726691078.xml","form_type":"4"}},{"id":1403593,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-18T20:24:45.000Z","date":"2024-09-17","kind":"sale","planned":true,"acquired":false,"shares":1445,"price":115.3176,"value":166633.932,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 18, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $115.04 to $115.64. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":11739,"source":{"system":"sec-edgar","filing":"0001649094-24-000069","document":"wk-form4_1726691078.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000069/wk-form4_1726691078.xml","form_type":"4"}},{"id":1403592,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-18T20:24:45.000Z","date":"2024-09-17","kind":"sale","planned":true,"acquired":false,"shares":241,"price":114.6372,"value":27627.5652,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 18, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $113.93 to $114.74. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":13184,"source":{"system":"sec-edgar","filing":"0001649094-24-000069","document":"wk-form4_1726691078.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000069/wk-form4_1726691078.xml","form_type":"4"}},{"id":1403591,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-18T20:24:45.000Z","date":"2024-09-17","kind":"exercise","planned":true,"acquired":true,"shares":6250,"price":22.7,"value":141875.0,"ownership":{"direct":true},"balance_after":13425,"source":{"system":"sec-edgar","filing":"0001649094-24-000069","document":"wk-form4_1726691078.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000069/wk-form4_1726691078.xml","form_type":"4"}},{"id":1484894,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-10T20:11:34.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":7250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":7250,"derivative":{"exercise_price":72.51,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":7250},"source":{"system":"sec-edgar","filing":"0001649094-24-000014","document":"wk-form4_1718050286.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000014/wk-form4_1718050286.xml","form_type":"4"}},{"id":1484893,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-10T20:11:34.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":1550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":7175,"source":{"system":"sec-edgar","filing":"0001649094-24-000014","document":"wk-form4_1718050286.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000164909424000014/wk-form4_1718050286.xml","form_type":"4"}},{"id":1597084,"issuer":{"id":4567,"kind":"organization","name":"COMPASS Pathways plc"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (Right to Buy)","published_at":"2024-03-05T22:06:24.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":117643,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares underlying this option vest and become exercisable on March 1, 2025, with the remainder vesting in thirty-six equal monthly installments thereafter."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":117643,"derivative":{"exercise_price":11.48,"exercise_date":"2025-03-01","expiration_date":"2034-02-28","underlying":"Ordinary Shares","underlying_shares":117643},"source":{"system":"sec-edgar","filing":"0001816590-24-000048","document":"wk-form4_1709676354.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816590/000181659024000048/wk-form4_1709676354.xml","form_type":"4"}},{"id":1597083,"issuer":{"id":4567,"kind":"organization","name":"COMPASS Pathways plc"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2024-03-05T22:06:24.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":62718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an award of Restricted Share Units (\"RSUs\") granted under the Issuer's 2020 Share Option and Incentive Plan. Each RSU represents a contingent right to receive one Ordinary Share. The RSUs vest in four equal annual installments, with the first installment vesting on March 1, 2025."}],"balance_after":62718,"source":{"system":"sec-edgar","filing":"0001816590-24-000048","document":"wk-form4_1709676354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816590/000181659024000048/wk-form4_1709676354.xml","form_type":"4"}},{"id":1854301,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-15T21:54:38.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 13, 2024 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":15000,"derivative":{"exercise_price":53.08,"expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-037505","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919123037505/doc4.xml","form_type":"4"}},{"id":1854300,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-15T21:54:38.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 13, 2024 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":5625,"source":{"system":"sec-edgar","filing":"0001209191-23-037505","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919123037505/doc4.xml","form_type":"4"}},{"id":2244713,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-03T20:32:21.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 1, 2023 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":18750,"derivative":{"exercise_price":22.7,"expiration_date":"2032-05-31","underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001209191-22-034066","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919122034066/doc4.xml","form_type":"4"}},{"id":2244712,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T20:32:21.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 1, 2023 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date."}],"balance_after":3125,"source":{"system":"sec-edgar","filing":"0001209191-22-034066","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919122034066/doc4.xml","form_type":"4"}},{"id":2564031,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-21T00:01:28.000Z","date":"2021-09-16","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option shall vest over 36 months, 1/3 of which will vest on September 16, 2022 and  1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date"}],"balance_after":30000,"derivative":{"exercise_price":26.37,"expiration_date":"2031-09-15","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-21-056967","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000120919121056967/doc4.xml","form_type":"4"}},{"id":2831878,"issuer":{"id":112267,"kind":"organization","name":"SQZ Biotechnologies Co","symbol":"SQZ"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2021-02-25T17:50:10.000Z","date":"2021-02-23","kind":"grant","acquired":true,"shares":75950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% of the underlying securities on February 23, 2022 and in 36 substantially equal monthly installments thereafter."}],"balance_after":75950,"derivative":{"exercise_price":16.85,"expiration_date":"2031-02-22","underlying":"Common Stock","underlying_shares":75950},"source":{"system":"sec-edgar","filing":"0000899243-21-008256","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604477/000089924321008256/doc4.xml","form_type":"4"}},{"id":2997169,"issuer":{"id":112267,"kind":"organization","name":"SQZ Biotechnologies Co","symbol":"SQZ"},"owners":[{"id":37684,"kind":"person","name":"Loxam Teri","position":1,"cik":"0001829111","reported_name":"Loxam Teri","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2020-10-30T18:31:39.000Z","date":"2020-10-29","kind":"grant","acquired":true,"shares":10530,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% of the underlying shares on October 29, 2021 and in 36 equal monthly installments thereafter."}],"balance_after":10530,"derivative":{"exercise_price":16,"expiration_date":"2030-10-28","underlying":"Common Stock","underlying_shares":10530},"source":{"system":"sec-edgar","filing":"0000899243-20-029983","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604477/000089924320029983/doc4.xml","form_type":"4"}}]}